Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high single doses failed to directly reduce cortical excitability compared to placebo, suggesting its anti-seizure effects may...
`Cannabinoid Clinical Trials: CBD and Cortical Excitability`
Clinical Takeaway In a controlled crossover trial of healthy adults, CBD at both low (30 mg) and high (700 mg) single doses showed no direct effect on cortical excitability compared to placebo....
Endocannabinoid System Research: CBD & Cortical Excitability
Clinical Takeaway In a controlled crossover trial in healthy adults, CBD at both low and high doses showed no direct effect on cortical excitability compared to placebo, suggesting its anti-seizure benefit may...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this rigorous crossover trial, neither a low nor a high single dose of CBD directly altered cortical excitability or produced measurable sedation in healthy adults. This suggests that CBD's...